Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson stands out as a diversified healthcare company that offers essential products and services, making it resilient during economic downturns. With a solid dividend yield of 2.28% and impressive returns of 51.13% over the past year, it appeals to investors seeking stability and growth. Analysts have a median 12-month price target of $252.50, reflecting confidence in the company's ability to deliver consistent performance.
Pros:
- Steady demand in weak economies
- Strong dividend yield
Cons:
- Market volatility risk
- Dependence on healthcare sector performance
Johnson & Johnson (JNJ) may be suitable for investors looking for a stable, dividend-paying stock with a strong track record of resilience and growth in the healthcare sector. Its solid performance metrics and diversified portfolio make it an attractive option for those seeking both income and capital appreciation in their long-term investment strategy.